Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record details and showing an access-denied message instead.SummaryDifference20%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page updated the revision label from v3.6.5 to v3.6.6, indicating a newer version of the study documents; this appears to be an administrative update rather than a substantive change to study information.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This signals a new site revision without changes to study content.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a small release update applied to the page’s underlying platform.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page revision line was updated from v3.6.2 to v3.6.3, indicating a small metadata update to the page without changes to the study information.SummaryDifference0.1%

- Check89 days agoChange DetectedThe study record revision was updated from v3.6.0 to v3.6.2, indicating a newer version of the documentation. This update appears administrative rather than affecting the study details.SummaryDifference0.1%

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.